We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Bronchogenic Carcinoma and Thromboembolic Disease

Richard B. Byrd, MC; Matthew B. Divertie, MD; John A. Spittell Jr., MD
JAMA. 1967;202(11):1019-1022. doi:10.1001/jama.1967.03130240061011.
Text Size: A A A
Published online

During a six-year period, thromboembolism occurred as an early complication in 37 patients with primary bronchogenic carcinoma. No other precipitating factor was identified, and only three of the 37 patients had previously undergone surgery. In 14 instances, an episode of thrombophlebitis first called attention to the patient's illness. Migratory thrombophlebitis involving unusual sites and resistant to anticoagulant therapy often preceded recognition of the tumor by as long as 18 months. The presence of thrombophlebitis was associated with a poor prognosis. The mechanism is obscure, but in three cases there was acceleration of factor III (thromboplastin) generation. No relationship was apparent between the histologic structure of the tumor and the frequency of venous thromboembolism. Even when lymph nodes are not palpable, bilateral supraclavicular exploration and lymph node biopsy appears to be a valuable and innocuous diagnostic procedure in patients with unexplained thrombophlebitis and is preferable to abdominal exploration. The true incidence of this complication is difficult to assess because of the uncertainties of retrospective diagnosis and follow-up.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.